Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Medicine, Oncology, Surgery +17

Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer

Eren D. Yeh, Priscilla J. Slanetz, Daniel B. Kopans et al. · American Journal of Roentgenology · 2005 · 406 citations

Medicine, Oncology, Radiology +17

Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype

Claudette E. Loo, Marieke E. Straver, Sjoerd Rodenhuis et al. · Journal of Clinical Oncology · 2011 · 306 citations

Medicine, Oncology, Radiology +17

Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer

Jennifer F. De Los Santos, Alan Cantor, Keith D. Amos et al. · Cancer · 2013 · 203 citations · Full text

Medicine, Oncology, Radiology +17

MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?

Kandace P. McGuire, Jorge Toro-Burguete, Hang Thi Thu Dang et al. · Annals of Surgical Oncology · 2011 · 126 citations

Medicine, Oncology, Radiology +15